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Introduction 
The Road Traffic Act 1994 prohibits driving under the 
influence of an intoxicant. The Act defines an intoxicant as 
including alcohol and drugs and any combination of drugs or 
of drugs and alcohol. The permitted legal limit for alcohol was 
set at 80 mg/100ml in blood, 107mg/100ml in urine, and 
35µg/100ml in breath. 
 Under the Act, the Medical Bureau of Road Safety 
(MBKS) is responsible for: 
• the receipt and analysis of specimens of blood and 
urine for the concentration of alcohol and for the 
presence (if any) of a drug or drugs; 
• the provision of equipment for the taking of such 
specimens; 
• approval, supply and testing of apparatus for 
indicating the presence of alcohol in the breath; 
• approval, supply and testing of apparatus for 
determining the concentration of alcohol in the breath. 
The number of specimens analysed by the MBRS has been 
increasing for both alcohol and drugs. 
Table 1 
Specimen numbers for alcohol and drug analysis by the 
MBRS 
Year Specimen type Alcohol analysis 
Drug
analysis
1995 blood and urine 4,766 8
1996 blood and urine 5,514 16
1997 blood and urine 6,591 24
1998 blood and urine 7,812 32
1999 blood and urine 8,476 50
2000   blood, urine 
and breath 
10,134 78
 
Analysis of Specimens 
The blood and urine specimens were analysed for the 
concentration of alcohol using Headspace Gas 
Chromatography. The breath specimens were analysed for 
alcohol concentration using either infra red spectroscopy (lion 
intoxilyzer 6000 IRL) or fuel cell technology 
(INTOXIMETER EC/IR). The blood and urine specimens 
were analysed for the presence of a drug or drugs using an 
ELISA system (COZART). The MBRS used the following 
microplate enzyme immunoassay kits: 
Table 2 
Cozart kits used by the MBRS to analyse for the 
presence of a drug of drugs in blood and urine 
specimens 
Kit Analyte 
Amphetamine Amphetamine 
Methylene- 
dioxyamphetamine 
(MDA) 
Methamphetamine Methylene- 
dioxymethamphetamine 
(MDMA) 
Benzodiazepine Diazepam 
Flunitrazepam, 
Flurazepam, Nitrazepam, 
Nordiazepam, 
Temazepam 
Cannabinoids 11-nor-delta-9- 
carboxy-tetrahydro- 
cannabinol 
Cocaine Cocaine, 
Benzolyecgonine, 
Ecgonine methyl ester 
Opiates Codeine, 
Dihydrocodeine, 
Morphine, 6 
Monoacetylmorphine 
(MAM) 
Methadone Methadone, 2- 
Ethylidene-1, 5-dimethyl-- 
3,3-diphenylpyrrolidine 
(EDDP) 
Specimens testing positive were forwarded to the State 
Laboratory for confirmatory analysis by either GC/MS or 
LC/MS. Confirmation was sought for all drugs and drug 
classes detected by the MBRS. Blood specimens were 
collected in 7-ml glass bijou bottles containing minimum 2 per 
cent sodium fluoride as preservative and I per cent potassium 
oxalate as anti-coagulant. Urine specimens were collected in 
2tSmi glass bottles containing minimum 1.5 per cent sodium 
fluoride as preservative. Not all blood specimens were of 7 ml 
volume nor urine specimens of 28 ml volume. 
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 All specimens were analysed on receipt or the 
following day for alcohol concentration and stored at 4ºC for 
at least three months. The length of time between date of 
provision of specimen and date of drug tests in the MBRS 
varied; the minimum time was 11 days and the maximum time 
was 106 days, which was due to a delay in the drug request. 
Final results of analysis were required within six months of the 
date on which the specimen was provided for prosecution 
purposes. 
Alcohol Results 
In 2000, 93 per cent of blood specimens, 91 per cent of urine 
specimens and 82 per cent of breath specimens were over the 
limit. In the same year, 57 per cent of blood specimens, 66 per 
cent of urine specimens and 33 per cent of breath specimens 
were over twice the limit. 
Table 3 
Certified alcohol content of blood specimens 
LEVELS 
mg/100ml 
NUMBERS PERCENTAGE
%
0-80 269 6.8
81-100 173 4.4
101-150 757 19.2
151-200 1,143 28.9
200 1,610 40.7
Table 4 
Certified alcohol content of breath specimens 
LEVELS 
µg/100ml 
NUMBERS PERCENTAGE
%
0-35 548 17.8
36-44 278 9.1
45-66 1.022 33.2
67-88 861 28.0
>88 366 11.9
Table 5 
Certified alcohol content of breath specimens 
LEVELS 
µg/100ml 
NUMBERS PERCENTAGE
%
0-107 226 8.8
108-135 154 6,0
136-200 578 22.6
201-267 838 32.8
>267 763 29.8
 
 
Drug Results 
Of the 78 specimens tested for the presence of a drug or drugs, 
37 were blood specimens and 41 urine specimens. Of these, 34 
blood specimens and 37 urine specimens were found to be 
positive, while seven specimens were negative for the drug or 
drug classes tested (three blood and four urine specimens). 
There were 23 specimens found positive for one drug class and 
48 for more than one drug. 
Table 6 
Drugs found using Cozart immunoassay screening tests 
specimens cut-off values  
blood urine mg/ml 
amphetamine 11 21 50 (B) 300 (U) 
methamphetamine 13 11 50 (B) 300 (U) 
benzo- 
diazepine 
14 22 100 (B) 100 (U) 
cannabinoids 22 31 20 (B) 20 (U) 
cocaine 1 5 100 (B) 100 (U) 
opiates 5 22 100 (B) 100 (U) 
Methadone 6 12 25 (B) 25 (U) 
Table 7 
Drugs found in blood and urine specimens using Cozart 
Immunoassay screening tests 
 percentage of total
Cannabinoid 32%
Benzodiazepines 19%
Methamphetamine 18%
Amphetamine 15%
Methadone 8%
Opiates 7%
Cocaine 1%
The bureau forwarded 71 specimens to the State Laboratory 
for confirmation of results before final issuing of reports for 
prosecution purposes. 
 The data indicated frequent polydrug use: 66 per cent 
of the confirmed specimens contained two or more drugs, and 
10 per cent of the specimens were confirmed with four or 
more drugs present. Cannabis, amphetamines and 
benzodiazepines were the most frequent drug groups found. 
Cocaine was the least common drug found. 
 In total, 79 per cent of the drug request specimens in 
2000 were found positive for the presence of a drug or drugs, 
15 per cent were unconfirmed and 6 per cent were found 
insufficient for analysis. 
 Combining the drug results with the alcohol results for 
the same specimens, 47 were under the limit for 
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Figure 1 
State Laboratory confirmatory blood results 
 
Figure 2 
State Laboratory confirmatory urine results 
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Figure 3 
Frequency of polydrug use in positive specimens 
 
Figure 4 
Drug analysis of Road Traffic Act Specimens 
 
 
alcohol and contained drugs, nine were over the limit for 
alcohol and contained drugs, and only two were found to be 
negative for alcohol and drugs. 
Conclusions 
The number of requests for the presence of drugs in RTA 
blood and urine specimens is increasing annually and the high 
percentage of positives found in the specimens tested indicates 
the need for such analyses. 
 The results showed excellent agreement for drug 
detection in the blood specimens analysed by the different 
methods, except for the cannabinoids. The lack of 
confirmation of the presence of cannabinoids in the blood 
specimens will need special attention. The results from the 
urine tests gave mixed agreement. Specimen stability, cross 
reactivity and choice of cut-off values may have contributed to 
the disparity in the results. As the driver is permitted under the 
Road Traffic Act to provide either a blood or urine specimen 
for analysis, it is necessary to provide a method of analysis for 
these substances in both types of specimens. 
 
 
 
 The number of specimens in this study is small and 
care must be exercised in interpreting the results. The MBRS 
is currently undertaking a larger survey, involving the analysis 
of 2000 specimens both over and under the limit for alcohol 
and drugs. This data should he available in 2002 and will 
hopefully assist in assessing intoxicant driving trends and the 
Bureau’s analytical needs. 
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